Table 2.

Predictors of survival after treatment.

Variable	Univariate Hazard Ratio	(95% CI)	p-value	Multivariate Hazard Ratio	(95% CI)	p-value
Age	1	(.98, 1.04)	0.54	1.01	(.97, 1.07)	0.57
Gender	0.86	(.4, 1.87)	0.71	0.69	(.26, 1.85)	0.46
Race	0.96	(.33, 2.8)	0.94	1.21	(.34, 4.34)	0.77
Education	0.99	(.46, 2.1)	0.97	1.36	(.46, 4.00)	0.57
Estimated IQ	0.96	(.93, .99)	0.0084	0.95	(.91, 1.00)	0.036
Hollingshead	1.01	(.98, 1.03)	0.59	1	(.96, 1.04)	0.87
POMS	1.02	(.98, 1.06)	0.28	—	—	—
FLIC	0.99	(.97, 1.0)	0.099	1.02	(.99, 1.05)	0.26
SF-36, MCS	0.99	(.96, 1.03)	0.59	—	—	—
SF-36, PCS	0.95	(.91, .98)	0.0039	0.96	(.90, 1.03)	0.12
LT Cocaine	3.11	(1.17, 8.26)	0.023	6.03	(1.08, 33.86)	0.041
LT Alcohol	1.13	(.49, 2.6)	0.78	1.37	(.49, 3.82)	0.55
LT Cannabis	0.87	(.26, 2.92)	0.93	0.45	(.07, 2.97)	0.41
CML1	8.44	(3.23, 22.1)	<.0001	1.87	(.48, 7.24)	0.37
MDS2	5.47	(1.9, 15.7)	0.0016	1.79	(.34, 9.52)	0.5
Treatment3	2.53	(1.14, 5.6)	0.022	2.36	(.79, 7.04)	0.12
Hemoglobin4	0.59	(.47, .75)	<.0001	0.6	(.43, .83)	0.0022

¹Comparison between CML-Accelerated Phase and CML-Stable Phase.

²Comparison between MDS and CML-Stable Phase.

³Comparison between HSCT and other treatment.

⁴Hemoglobin at study enrollment.